Organization of enzyme concentration across the metabolic network in cancer cells

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Madhukar, Neel S ^a,b,c   Warmoes, Marc O ^a   Locasale, Jason W ^a,b,c  

^a Department of Obstetrics Gynecology   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE ISOENZYME 2; FATTY ACID SYNTHASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE 2; LACTATE DEHYDROGENASE; PHOSPHOGLYCERATE DEHYDROGENASE; PHOSPHOGLYCERATE MUTASE; PROTEOME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; COENZYME;

ARTICLE; CANCER CELL; CANCER CELL LINE; CELL LEVEL; CELL METABOLISM; ENZYME ANALYSIS; GLYCOLYSIS; HUMAN; HUMAN CELL; MASS SPECTROMETRY; MATHEMATICAL MODEL; METABOLIC FLUX ANALYSIS; OXIDATION REDUCTION POTENTIAL; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; THERMODYNAMICS; COENZYME; METABOLISM; PROTEIN TRANSPORT; TUMOR CELL LINE;

CELL LINE, TUMOR; COENZYMES; GLYCOLYSIS; HUMANS; PROTEIN TRANSPORT; PROTEOME;

EID: 84922022722     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117131     Document Type: Article

References (41)

1. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033. doi: 10.1126/science.1160809 PMID: 19460998
2. DeBerardinis RJ, Thompson CB (2012) Cellular metabolism and disease: what do metabolic outliers teach us? Cell 148: 1132-1144. doi: 10.1016/j.cell.2012.02.032 PMID: 22424225
3. Hu J, Locasale JW, Bielas JH, O'Sullivan J, Sheahan K, et al. (2013) Heterogeneity of tumor-induced gene expression changes in the human metabolic network. Nat Biotechnol 31: 522-529. doi: 10.1038/ nbt.2530 PMID: 23604282
4. Metallo CM, Vander Heiden MG (2013) Understanding metabolic regulation and its influence on cell physiology. Mol Cell 49: 388-398. doi: 10.1016/j.molcel.2013.01.018 PMID: 23395269
5. Warmoes MO, Locasale JW (2014) Heterogeneity of glycolysis in cancers and therapeutic opportunities. Biochem Pharmacol.
6. Kim MS, Pinto SM, Getnet D, Nirujogi RS, Manda SS, et al. (2014) A draft map of the human proteome. Nature 509: 575-581. doi: 10.1038/nature13302 PMID: 24870542
7. Northrop DB, Simpson FB (1998) Kinetics of enzymes with isomechanisms: britton induced transport catalyzed by bovine carbonic anhydrase II, measured by rapid-flow mass spectrometry. Arch Biochem Biophys 352: 288-292. PMID: 9587418
8. Deberardinis RJ, Sayed N, Ditsworth D, Thompson CB (2008) Brick by brick: metabolism and tumor cell growth. Curr Opin Genet Dev 18: 54-61. doi: 10.1016/j.gde.2008.02.003 PMID: 18387799
9. Nilsson R, Jain M, Madhusudhan N, Sheppard NG, Strittmatter L, et al. (2014) Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer. Nat Commun 5: 3128. doi: 10.1038/ncomms4128 PMID: 24451681
10. Schulze A, Harris AL (2012) How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 491: 364-373. doi: 10.1038/nature11706 PMID: 23151579
11. Vazquez A, Tedeschi PM, Bertino JR (2013) Overexpression of the mitochondrial folate and glycineserine pathway: a new determinant of methotrexate selectivity in tumors. Cancer Res 73: 478-482. doi: 10.1158/0008-5472.CAN-12-3709 PMID: 23135910
12. Chen G, Gharib TG, Huang CC, Taylor JM, Misek DE, et al. (2002) Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 1: 304-313. PMID: 12096112
13. Greenbaum D, Colangelo C, Williams K, Gerstein M (2003) Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 4: 117. PMID: 12952525
14. Maier T, Guell M, Serrano L (2009) Correlation of mRNA and protein in complex biological samples. FEBS Lett 583: 3966-3973. doi: 10.1016/j.febslet.2009.10.036 PMID: 19850042
15. Yates JR, Ruse CI, Nakorchevsky A (2009) Proteomics by mass spectrometry: approaches, advances, and applications. Annu Rev Biomed Eng 11: 49-79. doi: 10.1146/annurev-bioeng-061008-124934 PMID: 19400705
16. Breker M, Schuldiner M (2014) The emergence of proteome-wide technologies: systematic analysis of proteins comes of age. Nat Rev Mol Cell Biol 15: 453-464. doi: 10.1038/nrm3821 PMID: 24938631
17. Milo R (2013) What is the total number of protein molecules per cell volume? A call to rethink some published values. Bioessays 35: 1050-1055. doi: 10.1002/bies.201300066 PMID: 24114984
18. Shoemaker RH (2006) The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 6: 813-823. PMID: 16990858
19. Moghaddas Gholami A, Hahne H, Wu Z, Auer FJ, Meng C, et al. (2013) Global proteome analysis of the NCI-60 cell line panel. Cell Rep 4: 609-620. doi: 10.1016/j.celrep.2013.07.018 PMID: 23933261
20. Karnovsky A, Weymouth T, Hull T, Tarcea VG, Scardoni G, et al. (2012) Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data. Bioinformatics 28: 373-380. doi: 10.1093/bioinformatics/btr661 PMID: 22135418
21. Kohl M, Wiese S, Warscheid B (2011) Cytoscape: software for visualization and analysis of biological networks. Methods Mol Biol 696: 291-303. doi: 10.1007/978-1-60761-987-1-18 PMID: 21063955
22. Thiele I, Swainston N, Fleming RM, Hoppe A, Sahoo S, et al. (2013) A community-driven global reconstruction of human metabolism. Nat Biotechnol 31: 419-425. doi: 10.1038/nbt.2488 PMID: 23455439
23. Henry CS, Jankowski MD, Broadbelt LJ, Hatzimanikatis V (2006) Genome-scale thermodynamic analysis of Escherichia coli metabolism. Biophys J 90: 1453-1461. PMID: 16299075
24. Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28: 27-30. PMID: 10592173
25. Altenberg B, Greulich KO (2004) Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84: 1014-1020. PMID: 15533718
26. Argiles JM, Lopez-Soriano FJ (1990) Why do cancer cells have such a high glycolytic rate? Med Hypotheses 32: 151-155. PMID: 2142979
27. Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891-899. PMID: 15516961
28. Gatenby RA, Gillies RJ (2007) Glycolysis in cancer: a potential target for therapy. Int J Biochem Cell Biol 39: 1358-1366. PMID: 17499003
29. Kim JW, Dang CV (2006) Cancer's molecular sweet tooth and the Warburg effect. Cancer Res 66: 8927-8930. PMID: 16982728
30. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, et al. (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452: 230-233. doi: 10.1038/nature06734 PMID: 18337823
31. Dang CV (2013) Role of aerobic glycolysis in genetically engineered mouse models of cancer. BMC Biol 11: 3. doi: 10.1186/1741-7007-11-3 PMID: 23342984
32. Fan J, Ye J, Kamphorst JJ, Shlomi T, Thompson CB, et al. (2014) Quantitative flux analysis reveals folate- dependent NADPH production. Nature 510: 298-302. doi: 10.1038/nature13236 PMID: 24805240
33. Shestov AA, Liu X, Ser Z, Cluntun AA, Hung YP, et al. (2014) Quantitative determinants of aerobic glycolysis identify flux through the enzyme GAPDH as a limiting step. Elife: e03342.
34. Lee K, Ban HS, Naik R, Hong YS, Son S, et al. (2013) Identification of malate dehydrogenase 2 as a target protein of the HIF-1 inhibitor LW6 using chemical probes. Angew Chem Int Ed Engl 52: 10286-10289. doi: 10.1002/anie.201304987 PMID: 23934700
35. Doherty JR, Cleveland JL (2013) Targeting lactate metabolism for cancer therapeutics. J Clin Invest 123: 3685-3692. doi: 10.1172/JCI69741 PMID: 23999443
36. Warmoes M, Jaspers JE, Xu G, Sampadi BK, Pham TV, et al. (2013) Proteomics of genetically engineered mouse mammary tumors identifies fatty acid metabolism members as potential predictive markers for cisplatin resistance. Mol Cell Proteomics 12: 1319-1334. doi: 10.1074/mcp.M112.024182 PMID: 23397111
37. Noor E, Bar-Even A, Flamholz A, Reznik E, Liebermeister W, et al. (2014) Pathway thermodynamics highlights kinetic obstacles in central metabolism. PLoS Comput Biol 10: e1003483. doi: 10.1371/ journal.pcbi.1003483 PMID: 24586134
38. Birsoy K, Possemato R, Lorbeer FK, Bayraktar EC, Thiru P, et al. (2014) Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides. Nature 508: 108-112. doi: 10.1038/nature13110 PMID: 24670634
39. Labuschagne CF, van den Broek NJ, Mackay GM, Vousden KH, Maddocks OD (2014) Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. Cell Rep 7: 1248-1258. doi: 10.1016/j.celrep.2014.04.045 PMID: 24813884
40. Jain M, Nilsson R, Sharma S, Madhusudhan N, Kitami T, et al. (2012) Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 336: 1040-1044. doi: 10.1126/science.1218595 PMID: 22628656
41. Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26: 1367-1372. doi: 10. 1038/nbt.1511 PMID: 19029910